Skip to content

Clinical trials

Phase 1/2 Obesity trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Phase: Phase 1/2 Country / region: United States Clear all

82 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20043
20055
20063
20071
20083
20091
20103
20114
20122
20138
20142
20152
20162
20173
20186
20192
20201
20213
20222
20235
20246
20255
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed52
Recruiting11
Terminated6
Active, not recruiting4
Withdrawn4
Unknown status3
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vanderbilt University Medical Center7
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)4
University of Pittsburgh4
Pennington Biomedical Research Center3
Stanford University3
Alnylam Pharmaceuticals2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2
Rhythm Pharmaceuticals, Inc.2
University of California, San Francisco2
University of Colorado, Denver2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity82
Overweight16
Weight Loss9
Diabetes Mellitus, Type 28
Hypertension7
Insulin Resistance7
Metabolic Syndrome7
Diabetes Mellitus4
Non-alcoholic Fatty Liver Disease4
Pediatric Obesity3

Trials

Showing 1 to 25 of 82. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.